149 related articles for article (PubMed ID: 17922682)
1. Expression of connective tissue growth factor is in agreement with the expression of VEGF, VEGF-C, -D and associated with shorter survival in gastric cancer.
Liu L; Li Z; Feng G; You W; Li J
Pathol Int; 2007 Nov; 57(11):712-8. PubMed ID: 17922682
[TBL] [Abstract][Full Text] [Related]
2. Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer.
Liu LY; Han YC; Wu SH; Lv ZH
World J Gastroenterol; 2008 Apr; 14(13):2110-4. PubMed ID: 18395916
[TBL] [Abstract][Full Text] [Related]
3. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor C and D expression correlates with lymph node metastasis and poor prognosis in patients with resected esophageal cancer.
Kozlowski M; Naumnik W; Niklinski J; Milewski R; Dziegielewski P; Laudanski J
Neoplasma; 2011; 58(4):311-9. PubMed ID: 21520987
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer.
Lin BR; Chang CC; Che TF; Chen ST; Chen RJ; Yang CY; Jeng YM; Liang JT; Lee PH; Chang KJ; Chau YP; Kuo ML
Gastroenterology; 2005 Jan; 128(1):9-23. PubMed ID: 15633118
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
7. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
Al-Moundhri MS; Al-Shukaili A; Al-Nabhani M; Al-Bahrani B; Burney IA; Rizivi A; Ganguly SS
World J Gastroenterol; 2008 Jun; 14(24):3879-83. PubMed ID: 18609713
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
9. DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer.
Matsumura S; Oue N; Mitani Y; Kitadai Y; Yasui W
Int J Cancer; 2007 Apr; 120(8):1689-95. PubMed ID: 17230534
[TBL] [Abstract][Full Text] [Related]
10. Correlation between Vascular Endothelial Growth Factor and Somatostatin Receptor with Progression and Prognosis in Gastric Cancer.
Zhao DQ; Chen J; Wu YF; Tian D; Zhou RX
Hepatogastroenterology; 2014 Jun; 61(132):1154-8. PubMed ID: 26158180
[TBL] [Abstract][Full Text] [Related]
11. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
[TBL] [Abstract][Full Text] [Related]
12. Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.
Baelde HJ; Eikmans M; Lappin DW; Doran PP; Hohenadel D; Brinkkoetter PT; van der Woude FJ; Waldherr R; Rabelink TJ; de Heer E; Bruijn JA
Kidney Int; 2007 Apr; 71(7):637-45. PubMed ID: 17264876
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
14. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.
Tang H; Wang J; Bai F; Zhai H; Gao J; Hong L; Xie H; Zhang F; Lan M; Yao W; Liu J; Wu K; Fan D
Cancer Invest; 2008 Feb; 26(1):60-7. PubMed ID: 18181047
[TBL] [Abstract][Full Text] [Related]
15. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
[TBL] [Abstract][Full Text] [Related]
16. High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients.
Chen J; Tang D; Wang S; Li QG; Zhang JR; Li P; Lu Q; Niu G; Gao J; Ye NY; Wang DR
Tumour Biol; 2014 Mar; 35(3):2513-9. PubMed ID: 24241899
[TBL] [Abstract][Full Text] [Related]
17. High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
Lin C; Zhang Z; Xu Y; Wang R; Chen S; Gao J; Wang D; Huang Q; Tu X; Wang L
Am J Clin Pathol; 2016 Sep; 146(3):278-88. PubMed ID: 27543975
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters.
Onogawa S; Kitadai Y; Amioka T; Kodama M; Cho S; Kuroda T; Ochiumi T; Kimura S; Kuwai T; Tanaka S; Chayama K
Cancer Lett; 2005 Aug; 226(1):85-90. PubMed ID: 16004935
[TBL] [Abstract][Full Text] [Related]
19. High lactate dehydrogenase 5 expression correlates with high tumoral and stromal vascular endothelial growth factor expression in gastric cancer.
Kim HS; Lee HE; Yang HK; Kim WH
Pathobiology; 2014; 81(2):78-85. PubMed ID: 24401755
[TBL] [Abstract][Full Text] [Related]
20. Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.
von Hardenberg J; Martini T; Knauer A; Ströbel P; Becker A; Herrmann E; Schubert C; Steidler A; Bolenz C
Urol Oncol; 2014 Jan; 32(1):54.e9-17. PubMed ID: 24360666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
